Literature DB >> 18422829

Long-term effects of heroin-assisted treatment in Germany.

Uwe Verthein1, Karin Bonorden-Kleij, Peter Degkwitz, Christoph Dilg, Wilfried K Köhler, Torsten Passie, Michael Soyka, Sabine Tanger, Mario Vogel, Christian Haasen.   

Abstract

AIMS: Trials in Switzerland, the Netherlands and Spain have found that heroin-assisted treatment (HAT) as maintenance treatment for opioid-dependent patients reduces illicit drug use. A German trial also found diamorphine treatment to be superior to methadone treatment. The present study describes the association between 2 years of heroin treatment and improvements in health and social stabilization, as well as illicit drug use.
DESIGN: A prospective cohort study design. PARTICIPANTS: A total of 515 patients were assigned to diamorphine treatment; 278 patients remained in the study treatment for the entire period of 24 months (54.8%). MEASUREMENTS: The results on physical (Opiate Treatment Index Health Symptoms Scale) and mental (Symptom Checklist 90-Revised Global Severity Index) health and illicit drug use (number of days with drug use within the last month-European Addiction Severity Index) were examined by repeated-measures analyses.
FINDINGS: Symptoms of physical (Pillai's trace = 0.837, df = 4, P < 0.001) and mental health (Pillai's trace = 0.450, df = 4, P < 0.001) improved during treatment. Street heroin use declined rapidly (Pillai's trace = 0.836, df = 4, P < 0.001), as did cocaine use (Pillai's trace = 0.280, df = 4, P < 0.001).
CONCLUSIONS: HAT is associated with improvements in mental and physical health in the long term.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422829     DOI: 10.1111/j.1360-0443.2008.02185.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  14 in total

1.  'The human prerogative': a critical analysis of evidence-based and other paradigms of care in substance abuse treatment.

Authors:  Eric Broekaert; Mieke Autrique; Wouter Vanderplasschen; Kathy Colpaert
Journal:  Psychiatr Q       Date:  2010-09

Review 2.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

Review 3.  Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.

Authors:  James Bell; Vendula Belackova; Nicholas Lintzeris
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

4.  [The impact of opening a heroin-assisted treatment clinic on the surrounding neighborhood].

Authors:  Marc-André Ally; Serge Brochu; Etienne Blais
Journal:  Can J Public Health       Date:  2011 May-Jun

5.  Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets.

Authors:  Ludwig Perger; Katharina M Rentsch; Gerd A Kullak-Ublick; Davide Verotta; Karin Fattinger
Journal:  Eur J Pharm Sci       Date:  2008-11-25       Impact factor: 4.384

Review 6.  Prescription of heroin for the management of heroin dependence: current status.

Authors:  Nicholas Lintzeris
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; Suzanne Brissette; Jill Chettiar; Pascal Schneeberger; David C Marsh; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  J Urban Health       Date:  2008-08-29       Impact factor: 3.671

Review 8.  Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.

Authors:  Nikolaj Kunøe; Philipp Lobmaier; Hanh Ngo; Gary Hulse
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

9.  Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; David C Marsh; Daphne Guh; Suzanne Brissette; Candice Gartry; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  Clin Trials       Date:  2009-06       Impact factor: 2.486

10.  The right medicine for World Drug Day.

Authors:  John H Halpern
Journal:  Indian J Med Res       Date:  2012-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.